Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biotricity Inc. (BTCY) had Revenue of $3.62M for the most recently reported fiscal quarter, ending 2024-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-12-31

Income Statement Financials
Revenue	$3.62M
Net Income	$-1.32M
Cost of Goods Sold	$0.86M
Gross Profit	$2.76M
Operating Expenses	$3.79M
Operating Income	$-0.17M
Non-Operating Income/Expense	$-1.06M
Pre-Tax Income	$-1.23M
Normalized Pre-Tax Income	$-1.23M
Income after Taxes	$-1.23M
Income from Continuous Operations	$-1.23M
Consolidated Net Income/Loss	$-1.23M
Normalized Income after Taxes	$-1.23M
EBIT	$-0.17M
EBITDA	$0.12M
Weighted-Average Shares Outstanding (Basic)	24.23M
Weighted-Average Shares Outstanding (Diluted)	24.23M
Earnings per Share (EPS) (Basic)	$-0.05
Earnings per Share (EPS) (Diluted)	$-0.05
Balance Sheet Financials
Current Assets	$4.86M
Property, Plant, and Equipment	$0.01M
Long-Term Assets	$1.13M
Total Assets	$5.99M
Current Liabilities	$21.14M
Long-Term Debt	$12.60M
Long-Term Liabilities	$16.79M
Total Liabilities	$37.93M
Common Equity	$-31.94M
Tangible Shareholders Equity	$-31.94M
Shareholders Equity	$-31.94M
Common Shares Outstanding	24.39M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.98M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$1.76M
Beginning Cash	$0.79M
End Cash	$0.51M
Increase/Decrease in Cash	$-0.28M
Stock-Based Compensation	$0.28M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	$-0.02M
Fundamental Metrics & Ratios
Current Ratio	0.23
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.65
Debt to Equity Ratio	-0.76
Gross Margin	76.37%
Operating Margin	-4.67%
EBIT Margin	-4.67%
EBITDA Margin	--
Pre-Tax Profit Margin	-33.96%
Profit Margin	-36.43%
Free Cash Flow	$-1.98M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.60
Inventory Turnover	0.54
Receiveable Turnover	2.93
Days Sales in Receivables	30.73
Return on Equity	3.85%
Return on Tangible Equity	3.85%
Return on Assets	-20.53%
Return on Investments	6.35%
Book Value Per Share	$-1.31
Free Cash Flow per Share	$-0.08
Operating Cash Flow per Share	$-0.08

Data from Zacks Investment Research, Inc.